COSCIENS Biopharma Inc. Net Fee Amt
COSCIENS Biopharma Inc. (CSCIF) had Net Fee Amt of $47.79 as of 2026-04-20, per its SC 13E3 filed 2026-04-20.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-04-20
- 2026-04-20: Net Fee Amt $47.79.
| Period end | Net Fee Amt |
|---|---|
| 2026-04-20 | $47.79 SC 13E3 · filed 2026-04-20 |